Patent · US Expired

Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof

US6069233A · kind A · utility

3Cited by

1References

2Claims

0Family size

Assignees

Memorial Sloan Kettering Cancer Center · US
Cornell Research Foundation, Inc. · US
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Yao-Tseng Chen · New York, US
Matthew Scanlan · Princeton Junction, US
Ali Gure · New York, US
Lloyd J. Old · New York, US
Ozlem Tureci · Homburg, DE
Ugur Sahin · Mainz, DE
Michael Pfreundschuh · Homburg, DE

Key dates

Filing date	Jan 26, 1998
Grant date	May 30, 2000
Priority date	—
Expiry date	Jan 26, 2018

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/806
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the isolation of a nucleic acid molecule which encodes an esophageal cancer associated antigen. Also a part of the invention is the antigen itself, and the uses of the nucleic acid molecule and the antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.